CVE-2024-34081

MantisBT Cross-site Scripting vulnerability

Description

MantisBT (Mantis Bug Tracker) is an open source issue tracker. Improper escaping of a custom field's name allows an attacker to inject HTML and, if CSP settings permit, achieve execution of arbitrary JavaScript when resolving or closing issues (`bug_change_status_page.php`) belonging to a project linking said custom field, viewing issues (`view_all_bug_page.php`) when the custom field is displayed as a column, or printing issues (`print_all_bug_page.php`) when the custom field is displayed as a column. Version 2.26.2 contains a patch for the issue. As a workaround, ensure Custom Field Names do not contain HTML tags.

Category

6.6
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.12%
Vendor Advisory github.com Vendor Advisory mantisbt.org
Affected: mantisbt mantisbt
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-34081?
CVE-2024-34081 has been scored as a medium severity vulnerability.
How to fix CVE-2024-34081?
To fix CVE-2024-34081, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-34081 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-34081 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-34081?
CVE-2024-34081 affects mantisbt mantisbt.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.